Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03678909 · ClinicalTrials.gov registry record
Cardiac Biomarkers in Patients With Single Ventricle Physiology
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 19
- Enrollment target
NCT03678909: Completed study, sponsored by Baylor College of Medicine.
NCT03678909 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03678909 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
All neonates with congenital heart disease undergoing stage one palliation (Norwood procedure, Damus-Kaye-Stansel procedure) at Texas Children's Hospital will be regularly monitored for B-type natriuretic peptide (BNP) and Troponin level before the surgical procedure, on arrival to the cardiac intensive care unit after their surgical procedure, every 6 hours during the first 24 hours of the post-operative period, followed by daily levels for the first week, and then weekly during patient's regular laboratory work up schedule. These cardiac biomarkers are linked to demographic, hemodynamic, respiratory, pharmacological data available via Sickbay.
Primary Outcome
Mortality up to anticipated Glenn Procedure
Interventions
- PROCEDURE Norwood Palliation / DKS / Damus-Kaye-Stansel procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2020-07-30 |
What the finished NCT03678909 record still lists
NCT03678909 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Norwood Palliation / DKS / Damus-Kaye-Stansel procedure is the first listed.
NCT03678909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03678909 about?
NCT03678909 is a clinical study titled "Cardiac Biomarkers in Patients With Single Ventricle Physiology". All neonates with congenital heart disease undergoing stage one palliation (Norwood procedure, Damus-Kaye-Stansel procedure) at Texas Children's Hospital will be regularly monitored for B-type natriuretic peptide (BNP) and Troponin level before the surgical procedure, on arrival to the cardiac inten...
What is the current status of trial NCT03678909?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2018-03-01. Estimated completion is 2020-07-30.
What interventions are being tested in trial NCT03678909?
The interventions under investigation include: Norwood Palliation / DKS / Damus-Kaye-Stansel procedure (PROCEDURE).
Who is sponsoring clinical trial NCT03678909?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI